Information was received from a healthcare provider (hcp) via a manufacturer representative on 2019-sep-30 regarding a patient receiving morphine (dose and concentration unknown) via an implanted infusion pump.The indication for use was spinal pain.It was reported that the patient had been experiencing a rash like symptom that per the hcp, looked more like an erythema.The patient was placed on topical steroid cream from their dermatologist, but ran out and couldn't get approval for more from their insurance.The patient was without the steroid cream for several weeks.Per the hcp, the patient reported what they described as blisters of new skin over the pump pocket.While shopping, the patient felt a releasing sensation and noticed their clothes and jacket were wet with fluid from the pocket.The patient left and went to the emergency room who bandaged the pocket site and sent the patient home.The patient presented to the emergency room again on (b)(6) 2019 and was again sent home.On (b)(6) 2019 the patient presented to the clinic and was admitted and brought into surgery where the pump and catheter were removed due to the pump eroding through the skin.The representative was unaware of any external factors that may have led or contributed to the issue or any troubleshooting performed related to the issue.Actions/interventions taken to resolve the issue included different topical creams given to the patient to try.The issue was considered resolved at the time of report and the patient's status was alive, no injury.No further complications were reported or anticipated.
|